1. Home
  2. Labeler Index
  3. Cangene Biopharma
  4. 53270-0270
  5. NDC Package Code: 53270-0270-5 Ixinity

NDC Package 53270-0270-5 Ixinity

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory .

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
53270-0270-5
Package Description:
1 KIT in 1 CARTON * 5 mL in 1 VIAL * 5 mL in 1 SYRINGE (53270-0280-1)
Product Code:
53270-0270
Proprietary Name:
Ixinity
Usage Information:
This medication is used to prevent or control bleeding in people with little or no factor IX (due to hemophilia B, Christmas disease). Factor IX is a protein (clotting factor) in the blood that works with other clotting factors to help the blood clot and therefore stop bleeding. People with little or no factor IX are at risk for bleeding longer after an injury/surgery or bleeding suddenly (often in the joints/muscle) without an obvious cause. This medication should not be used to treat other types of factor deficiencies (e.g., factors II, VII, VIII, X) or factor problems (e.g., inhibitor to factor XIII), to reverse the effects of "blood thinners" (e.g., warfarin), or to treat bleeding from low levels of liver-dependent clotting factors (due to liver problems).
11-Digit NDC Billing Format:
53270027005
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Labeler Name:
Cangene Biopharma
Sample Package:
No
FDA Application Number:
BLA125426
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
05-01-2015
End Marketing Date:
05-31-2018
Listing Expiration Date:
05-31-2018
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 53270-0270-5?

The NDC Packaged Code 53270-0270-5 is assigned to a package of 1 kit in 1 carton * 5 ml in 1 vial * 5 ml in 1 syringe (53270-0280-1) of Ixinity, labeled by Cangene Biopharma. The product's dosage form is and is administered via form.

Is NDC 53270-0270 included in the NDC Directory?

The product was first marketed by Cangene Biopharma on May 01, 2015 and its listing in the NDC Directory is set to expire on May 31, 2018 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 53270-0270-5?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

What is the 11-digit format for NDC 53270-0270-5?

The 11-digit format is 53270027005. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-153270-0270-55-4-253270-0270-05